Cathepsin B preferably cleaves wild-type β-secretase substrate, but not Swedish mutant substrate, which explains why E-64d-induced cathepsin B inhibition had no effect in AD mice expressing the Swedish mutant β-secretase site of APP [100]. Here, APP is linked to Alzheimer disease.